Once upon a time there were two kings of the pneumonia vaccine world, Pfizer and GSK. They charged countries different prices for the vaccine, and kept most of the prices secret. 

Then Gavi, the Vaccine Alliance, negotiated with the companies a discounted price for the poorest countries with a national income under $1,580 per capita.

More kids were vaccinated, but today nearly 1 million kids still die from pneumonia each year worldwide.

48% of kids’ deaths in Romania and 25% of kids’ deaths in Algeria are due to pneumonia, but the vaccine can't be purchased at Gavi’s discounted price in those countries. 

Don't you think countries who need it the most should get access to a fair price? We do.

We know that having competition will lower the price. The Serum Institute of India is working on a pneumonia vaccine, which they're planning to offer at $6 per child. But the vaccine probably won’t be available until 2019. 

That's still 4 years from now.  If we wait until then, potentially 4 million more kids will die waiting for the price to drop.


What if...

Instead of doing things the way they've always been done, we demand change and rewrite how this story ends?

We're asking Pfizer and GSK to lower the price of the pneumonia vaccine to $5 per kid... That’s half the current lowest price, which means potentially more could be vaccinated, and countries  who can’t afford the vaccine now can protect their children. 

It's not too late to have the future we image.


MSF has recently launched a global public campaign, A Fair Shot, to put pressure on the pharmaceutical companies, GSK and Pfizer, to drop the price of the pneumonia vaccine to US$ 5 a child (for all three doses). If you’d like to add your voice to the campaign, follow this link: